Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Figure 4

Randomized controlled trials of bisphosphonates in improving total hip BMD in IBD. Forest plot showing the weighted mean differences and 95% confidence interval of the percentage change in bone mineral density at the total hip in the bisphosphonate and control groups. A subgroup analysis of the treatment duration of the two groups is also shown.